ClariTrial | Search Clinical Trials

Explore/Breast Cancer

Status

Phase

19,287 results for “Breast Cancer”

Page 1 of 1286

Completed

Results posted

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

Phase 1Phase 2Metastatic Breast Cancer

DasatinibIxabepilone

Accelerated Community Oncology Research Network56 participants13 sites · United StatesCompletes Oct 2013

Compare CT.gov Full analysis →

Completed

Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients

N/ACancer of BreastCancer Colon

ONS Pre-op + ONS Post-opONS Pre-op + ONS Post-op + ONS Post-op 3 monthsUsual intake Pre-op + ONS Post-op

IMU University, Malaysia91 participants1 site · MalaysiaCompletes Jun 2021

Compare CT.gov Full analysis →

UNKNOWN

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

Phase 1Phase 2Breast Cancer

SHR-A1811 for injection ; capecitabine

Suzhou Suncadia Biopharmaceuticals Co., Ltd.116 participants9 sites · ChinaCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Palliative and Oncology Care Model in Breast Cancer

N/AMetastatic Breast Cancer

Palliative and Oncology CareStandard Oncology Care

Massachusetts General Hospital120 participants1 site · United StatesCompletes Sep 2019

Compare CT.gov Full analysis →

Completed

Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts

Phase 2Neoplasm

collaboration

National Cancer Institute (NCI)100 participants1 site · United States

Compare CT.gov Full analysis →

Recruiting

A Comparative Study of Nipple Sensation Preservation After Nipple-Sparing Mastectomy With Conventional, Endoscopic, Robotic Techniques

N/ASensation Disorder

Nipple Sensation Assessment

Candiolo Cancer Institute - IRCCS90 participants1 site · ItalyCompletes Dec 2027

Compare CT.gov Full analysis →

Active

Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

N/AOvarian CancerBRCA Mutation

Abramson Cancer Center at Penn Medicine24 participants1 site · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

Completed

IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

Phase 2Adenocarcinoma Breast Stage IV

IMP321 (eftilagimod alpha)PlaceboPaclitaxel

Immutep S.A.S.242 participants29 sites · Belgium, France, GermanyCompletes Mar 2020

Compare CT.gov Full analysis →

Terminated

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

Phase 1Phase 2Breast Cancer

PTK787Trastuzumab

Hoosier Cancer Research Network7 participants8 sites · United StatesCompletes Aug 2006

Compare CT.gov Full analysis →

Completed

Digital Breast Tomosynthesis Preference Study

N/ABreast Cancer

Digital Breast Tomosynthesis Exam

UNC Lineberger Comprehensive Cancer Center51 participants1 site · United StatesCompletes Apr 2010

Compare CT.gov Full analysis →

Recruiting

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Phase 2Triple Negative Breast CancerBreast Cancer

Capecitabine

Stanford University40 participants1 site · United StatesCompletes Nov 2026

Compare CT.gov Full analysis →

UNKNOWN

Asian Multicenter Prospective Study of ctDNA Sequencing

N/ACervical CancerOvarian Clear Cell CarcinomaNasopharyngeal Carcinoma

NGS analysis of ctDNA

National Cancer Center, Japan506 participants19 sites · Japan, Malaysia, PhilippinesCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

N/AGenetic Predisposition to DiseaseBreast Cancer FemaleOvarian Cancer

Sequential EHR Communications

Abramson Cancer Center at Penn Medicine1,283 participants1 site · United StatesCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

BREAST Choice Decision Tool R21 - AIM2

N/ABreast Cancer

Pre-surveyBREASTChoice tool.Post-survey

UNC Lineberger Comprehensive Cancer Center50 participants1 site · United StatesCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy

N/ACIPN in Adjuvant Colon Cancer PatientsCIPN in Adjuvant Breast Cancer Patients

OnLife

Swiss Medical Food AG150 participants1 site · GermanyCompletes Jul 2018

Compare CT.gov Full analysis →

1–15 of 19,287

Explore/Breast Cancer

Status

Phase

19,287 results for “Breast Cancer”

Page 1 of 1286

Completed

Results posted

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

Phase 1Phase 2Metastatic Breast Cancer

DasatinibIxabepilone

Accelerated Community Oncology Research Network56 participants13 sites · United StatesCompletes Oct 2013

Compare CT.gov Full analysis →

Completed

Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients

N/ACancer of BreastCancer Colon

ONS Pre-op + ONS Post-opONS Pre-op + ONS Post-op + ONS Post-op 3 monthsUsual intake Pre-op + ONS Post-op

IMU University, Malaysia91 participants1 site · MalaysiaCompletes Jun 2021

Compare CT.gov Full analysis →

UNKNOWN

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

Phase 1Phase 2Breast Cancer

SHR-A1811 for injection ; capecitabine

Suzhou Suncadia Biopharmaceuticals Co., Ltd.116 participants9 sites · ChinaCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Palliative and Oncology Care Model in Breast Cancer

N/AMetastatic Breast Cancer

Palliative and Oncology CareStandard Oncology Care

Massachusetts General Hospital120 participants1 site · United StatesCompletes Sep 2019

Compare CT.gov Full analysis →

Completed

Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts

Phase 2Neoplasm

collaboration

National Cancer Institute (NCI)100 participants1 site · United States

Compare CT.gov Full analysis →

Recruiting

A Comparative Study of Nipple Sensation Preservation After Nipple-Sparing Mastectomy With Conventional, Endoscopic, Robotic Techniques

N/ASensation Disorder

Nipple Sensation Assessment

Candiolo Cancer Institute - IRCCS90 participants1 site · ItalyCompletes Dec 2027

Compare CT.gov Full analysis →

Active

Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

N/AOvarian CancerBRCA Mutation

Abramson Cancer Center at Penn Medicine24 participants1 site · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

Completed

IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

Phase 2Adenocarcinoma Breast Stage IV

IMP321 (eftilagimod alpha)PlaceboPaclitaxel

Immutep S.A.S.242 participants29 sites · Belgium, France, GermanyCompletes Mar 2020

Compare CT.gov Full analysis →

Terminated

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

Phase 1Phase 2Breast Cancer

PTK787Trastuzumab

Hoosier Cancer Research Network7 participants8 sites · United StatesCompletes Aug 2006

Compare CT.gov Full analysis →

Completed

Digital Breast Tomosynthesis Preference Study

N/ABreast Cancer

Digital Breast Tomosynthesis Exam

UNC Lineberger Comprehensive Cancer Center51 participants1 site · United StatesCompletes Apr 2010

Compare CT.gov Full analysis →

Recruiting

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Phase 2Triple Negative Breast CancerBreast Cancer

Capecitabine

Stanford University40 participants1 site · United StatesCompletes Nov 2026

Compare CT.gov Full analysis →

UNKNOWN

Asian Multicenter Prospective Study of ctDNA Sequencing

N/ACervical CancerOvarian Clear Cell CarcinomaNasopharyngeal Carcinoma

NGS analysis of ctDNA

National Cancer Center, Japan506 participants19 sites · Japan, Malaysia, PhilippinesCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

N/AGenetic Predisposition to DiseaseBreast Cancer FemaleOvarian Cancer

Sequential EHR Communications

Abramson Cancer Center at Penn Medicine1,283 participants1 site · United StatesCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

BREAST Choice Decision Tool R21 - AIM2

N/ABreast Cancer

Pre-surveyBREASTChoice tool.Post-survey

UNC Lineberger Comprehensive Cancer Center50 participants1 site · United StatesCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy

N/ACIPN in Adjuvant Colon Cancer PatientsCIPN in Adjuvant Breast Cancer Patients

OnLife

Swiss Medical Food AG150 participants1 site · GermanyCompletes Jul 2018

Compare CT.gov Full analysis →

1–15 of 19,287